← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3320)
- Durvalumab plus carboplatin etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review. (2023/12/21) ♡
- RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants. (2023/12/19) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Metastatic small cell bladder cancer treated with sequential systemic therapy including pembrolizumab and amrubicin: A case report. (2023/12/19) ♡
- Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors? (2023/12/18) ♡
- A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC. (2023/12/18) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The First Case Report of Effective Treatment With Sotorasib for Metastatic Atypical Lung Carcinoid Harboring KRAS G12C Mutation and Aggressive Disseminated Lung Metastasis: A Case Report. (2023/12/15) ♡
- A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors. (2023/12/15) ♡
- VentX promotes tumor specific immunity and efficacy of immune checkpoint inhibitors. (2023/12/14) ♡
- Volumetric Modulated Arc Therapy Craniospinal Irradiation Utilizing a Vertebral Body Sparing Approach: An Alternative Approach to Improve Access and Minimize Toxicity. (2023/12/14) ♡
- SVM-DO: identification of tumor-discriminating mRNA signatures via support vector machines supported by Disease Ontology. (2023/12/14) ♡
- Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway. (2023/12/13) ♡
- The Naples Prognostic Score Is a Useful Tool to Assess Surgical Treatment in Non-Small Cell Lung Cancer. (2023/12/12) ♡
- Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events. (2023/12/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis. (2023/12/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Adjunctive effect of compound Kushen injection for cancer: An overview of systematic reviews. (2023/12/05) ♡
- Study on the material basis and action mechanisms of sophora davidii (Franch.) skeels flower extract in the treatment of non-small cell lung cancer. (2023/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Effect of Prehabilitation in Lung Cancer Patients Undergoing Lobectomy: A Review. (2023/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dabrafenib Therapy and BRAF Genotype. (2023/12/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy: a narrative review. (2023/12/04) ♡
- Differential Effect of Consolidative Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer Based on Sex. (2023/12/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Suspected NUT carcinoma progressing on pembrolizumab, carboplatin, and paclitaxel as first-line treatment: a case report. (2023/12/02) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Intraventricular metastases from small cell carcinoma of lung - comment on paper by Chen et al. (2023/12/01) ♡
- Gemcitabine enhances pharmacokinetic exposure of the major components of Danggui Buxue Decoction in rat via the promotion of intestinal permeability and down-regulation of CYP3A for combination treatment of non-small cell lung cancer. (2023/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Immunotherapy combined with Bianzheng traditional Chinese medicine for advanced lung cancer: A preliminary experience. (2023/12/01) ♡
- Different Endotracheal Intubations for Non-Small Cell Lung Cancer Surgery: A Retrospective-Case-Matched Study on Postoperative Complications and Quality of Life. (2023/12/01) ♡
- Survival outcomes and prognostic nutritional index in very elderly small-cell lung cancer patients: importance of active treatment and nutritional support. (2023/12/01) ♡
- Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non-small cell lung cancer patients with neoadjuvant immunotherapy. (2023/12/01) ♡
- Identifying genes associated with resistance to KRAS G12C inhibitors via machine learning methods. (2023/12/01) ♡
- Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC). (2023/12/01) ♡
- Association of plasma branched-chain amino acid with multiple cancers: A mendelian randomization analysis. (2023/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. First-line immunotherapy in non-small cell lung cancer: how to select and where to go. (2023/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Recurrence-Free Survival for One Year after Surgery, Radiotherapy, and Chemotherapy for Stage Ⅳ Lung Cancer]. (2023/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Intestinal Fistula Associated with Small Intestinal Metastasis from Small Cell Lung Carcinoma]. (2023/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [A Case of Neuroendocrine Carcinoma of the Extrahepatic Bile Duct]. (2023/12/01) ♡
- [Interest of focal radiotherapy in case of oligoprogression under immunotherapy in the treatment of metastatic non-small cell lung cancer]. (2023/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia. (2023/12/01) ♡
- Comprehensive sampling of the lung microbiome in early-stage non-small cell lung cancer. (2023/11/30) ♡
- Network pharmacology‑based investigation of potential targets of triptonodiol acting on non-small-cell lung cancer. (2023/11/28) ♡
- Inhibiting G6PD by quercetin promotes degradation of EGFR T790M mutation. (2023/11/28) ♡
- The Perceived Value of Liquid Biopsy: Results From a Canadian Validation Study of Circulating Tumor DNA T790M Testing-Patient's Willingness-to-Pay: A Brief Report. (2023/11/28) ♡
- Clinical efficacy of Camrelizumab combined with first-line chemotherapy in extensive-stage small-cell lung cancer (2023/11/28) ♡
- Treatment pattern and outcomes of leptomeningeal carcinomatosis in India - a retrospective study. (2023/11/27) ♡
- Comprehensive value implications of surgeon volume for lung cancer surgery: Use of an analytic framework within a regional health system. (2023/11/24) ♡
- Lobe-specific lymph node sampling is associated with lower risk of cancer recurrence. (2023/11/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in the role of circulating tumor cell heterogeneity in metastatic small cell lung cancer. (2023/11/22) ♡
- Real-World Data on Treatment Outcome of ALK-Positive Non-Small Cell Lung Cancer from an Indian Multicentric Cancer Registry. (2023/11/21) ♡
- LCMR1 Promotes Large-Cell Lung Cancer Proliferation and Metastasis by Downregulating HLA-Encoding Genes. (2023/11/16) ♡
- A quantitative evaluation method utilizing the homology concept to assess the state of chromatin within the nucleus of lung cancer. (2023/11/09) ♡
- Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer. (2023/11/03) ♡
- Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. (2023/11/02) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.